세계의 발가락 굽음증(망치 발가락) 시장 규모 : 유형별, 진단별, 치료별, 최종 사용자별, 지역별 및 예측

Hammertoe Market Size And Forecast

Hammertoe Market size was valued at USD 12.69 Billion in 2024 and is projected to reach USD 29.88 Billion by 2031 , growing at a CAGR of 11.30% during the forecast period 2024-2031.

Global Hammertoe Market Drivers

The market drivers for the Hammertoe Market can be influenced by various factors. These may include:

Growing Incidence Rates:

The aging population, sedentary lifestyles, and inappropriate footwear choices are major contributors to the rising incidence of hammertoe diseases.

Technological developments:

The creation of sophisticated orthopaedic equipment and advances in minimally invasive surgical methods are broadening the range of available treatments, which is propelling market expansion.

Increasing Awareness and Diagnosis:

Better diagnostic tools along with increased knowledge of foot abnormalities are enabling early identification and management of hammertoe, which is driving greater demand.

Preference for Non-Invasive Treatments:

The market is driven by patients' increasing preference for minimally invasive or non-invasive treatment choices, such as splints and orthotic devices.

Growing Healthcare Expenditure:

The global increase in healthcare spending, together with the development of healthcare facilities, is making it easier for people with hammertoes to receive treatment alternatives, which is driving the market's expansion.

Global Hammertoe Market Restraints

Several factors can act as restraints or challenges for the Hammertoe Market. These may include:

Exorbitant therapy Costs:

Some patients may find the costs of hammertoe therapy, which include surgery, orthotic devices, and follow-up care, to be unaffordable, which could restrict market expansion.

Restricted payment rules:

Patients may be discouraged from seeking essential care, which could impede market expansion, if there is insufficient insurance coverage or restricted payment rules for hammertoe treatment procedures and devices.

consequences and Risks

: Although treatment methods have improved, hammertoe procedures still have certain inherent risks and potential consequences. These include nerve injury, infection, and recurrence. As a result, patients may be discouraged from undertaking treatment, which could hinder market growth.

Alternative Therapy Options:

For certain patients, alternative therapies including physical therapy, acupuncture, and home remedies may be more effective than traditional hammertoe treatments. This could lower the need for medical interventions and have an impact on the growth of the market.

Lack of Knowledge in Developing Areas:

Patients may choose to forego prompt medical assistance or turn to traditional remedies due to a lack of knowledge regarding hammertoe problems and treatment alternatives, especially in developing areas. This can impede market growth.

Global Hammertoe Market Segmentation Analysis

Global Hammertoe Market is Segmented based on the Type, Diagnosis, Treatment, End User, And Geography.

By Type

Flexible hammertoe

Rigid hammertoe

Based on the type, the market is bifurcated into Flexible hammertoe and Rigid hammertoe. The flexible hammertoe is when the toe can still be moved while rigid hammertoe is a condition when the toe becomes rigid & they press the joint out of alignment.

By Diagnosis

Physical exam

X-rays

Others

Based on the diagnosis, the market is bifurcated into a Physical exam, X-rays, and Others. The growing number of hammertoe correction surgeries is predicted to bolster the market in the coming years.

By Treatment

Drugs

Orthotic Devices

Surgery

Others

Based on treatment, the market is bifurcated into Drugs, Orthotic Devices, Surgery, and Others. The surgery sector is anticipated to have the biggest market share. The variables are attributable to the rise in hammertoe procedures.

By End-User

Hospitals

Clinics

Physiotherapy & Orthopedic Centers

Based on the end-user, the market is bifurcated into Hospitals, Clinics, and Physiotherapy & Orthopedic Centers. The hospital segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the increasing number of patients with capsular tears & fractures and the rise in the number of orthopedic surgeries.

By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on the geographical analysis, the market is bifurcated into North America, Europe, Asia Pacific, and Rest of the world. The largest share in the market will be dominated by North America owing to the rising number of orthopedic specialty care centers & trauma care centers and the growth in the number of players manufacturing hammertoe correction products in this region.

Key Players

The major players in the Hammertoe Market are:

Stryker

Ex Extremity Medical LLC

Smith & Nephew plc

Zimmer Biomet (formerly Biomet)

Arthrex

Wright Medical Group N.V.

Acumed

OsteoMed

Nextremity Solutions, Inc.

Instratek

Extremity Medical LLC

Arrowhead Medical Device Technologies

Nextremity Solutions

Biometmith & Nephew plc.

Biomet, Inc.

Acumed.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL HAMMERTOE MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Hammertoe Market Geographical Analysis (CAGR %)
• 3.6 Global Hammertoe Market, By Type (USD Million)
• 3.7 Global Hammertoe Market, By Diagnosis (USD Million)
• 3.8 Global Hammertoe Market, By Treatment (USD Million)
• 3.9 Global Hammertoe Market, By End-User (USD Million)
• 3.10 Future Market Opportunities
• 3.11 Global Market Split
• 3.12 Product Life Line

4 GLOBAL HAMMERTOE MARKET OUTLOOK

• 4.1 Global Aquaculture Vaccines Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL HAMMERTOE MARKET, BY TYPE

• 5.1 Overview
• 5.2 Flexible hammertoe
• 5.3 Rigid hammertoe

6 GLOBAL HAMMERTOE MARKET, BY DIAGNOSIS

• 6.1 Overview
• 6.2 Physical exam
• 6.3 X-rays
• 6.4 Others

7 GLOBAL HAMMERTOE MARKET, BY TREATMENT

• 7.1 Overview
• 7.2 Drugs
• 7.3 Orthotic Devices
• 7.4 Surgery
• 7.5 Others

8 GLOBAL HAMMERTOE MARKET, BY END-USER

• 8.1 Overview
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Physiotherapy & Orthopedic Centers

9 GLOBAL HAMMERTOE MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Argentina
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 UAE
  • 9.6.2 Saudi Arabia
  • 9.6.3 South Africa
  • 9.6.4 Rest of Middle-East and Africa

10 GLOBAL HAMMERTOE MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Developments
• 10.4 Company Regional Footprint
• 10.5 Company Industry Footprint
• 10.6 ACE Matrix

11 COMPANY PROFILES

• 11.1 BioPro
  • 11.1.1 Company Overview
  • 11.1.2 Company Insights
  • 11.1.3 Product Benchmarking
  • 11.1.4 Key Developments
  • 11.1.5 Winning Imperatives
  • 11.1.6 Current Focus & Strategies
  • 11.1.7 Threat from Competition
  • 11.1.8 SWOT Analysis
• 11.2 Instratek
  • 11.2.1 Company Overview
  • 11.2.2 Company Insights
  • 11.2.3 Product Benchmarking
  • 11.2.4 Key Developments
  • 11.2.5 Winning Imperatives
  • 11.2.6 Current Focus & Strategies
  • 11.2.7 Threat from Competition
  • 11.2.8 SWOT Analysis
• 11.3 Stryker
  • 11.3.1 Company Overview
  • 11.3.2 Company Insights
  • 11.3.3 Product Benchmarking
  • 11.3.4 Key Developments
  • 11.3.5 Winning Imperatives
  • 11.3.6 Current Focus & Strategies
  • 11.3.7 Threat from Competition
  • 11.3.8 SWOT Analysis
• 11.4 Extremity Medical LLC
  • 11.4.1 Company Overview
  • 11.4.2 Company Insights
  • 11.4.3 Product Benchmarking
  • 11.4.4 Key Developments
  • 11.4.5 Winning Imperatives
  • 11.4.6 Current Focus & Strategies
  • 11.4.7 Threat from Competition
  • 11.4.8 SWOT Analysis
• 11.5 Arrowhead Medical Device Technologies
  • 11.5.1 Company Overview
  • 11.5.2 Company Insights
  • 11.5.3 Product Benchmarking
  • 11.5.4 Key Developments
  • 11.5.5 Winning Imperatives
  • 11.5.6 Current Focus & Strategies
  • 11.5.7 Threat from Competition
  • 11.5.8 SWOT Analysis
• 11.6 Wright Medical Group N.V.
  • 11.6.1 Company Overview
  • 11.6.2 Company Insights
  • 11.6.3 Product Benchmarking
  • 11.6.4 Key Developments
  • 11.6.5 Winning Imperatives
  • 11.6.6 Current Focus & Strategies
  • 11.6.7 Threat from Competition
  • 11.6.8 SWOT Analysis
• 11.7 Nextremity Solutions
  • 11.7.1 Company Overview
  • 11.7.2 Company Insights
  • 11.7.3 Product Benchmarking
  • 11.7.4 Key Developments
  • 11.7.5 Winning Imperatives
  • 11.7.6 Current Focus & Strategies
  • 11.7.7 Threat from Competition
  • 11.7.8 SWOT Analysis
• 11.8 Biometmith & Nephew plc.
  • 11.8.1 Company Overview
  • 11.8.2 Company Insights
  • 11.8.3 Product Benchmarking
  • 11.8.4 Key Developments
  • 11.8.5 Winning Imperatives
  • 11.8.6 Current Focus & Strategies
  • 11.8.7 Threat from Competition
  • 11.8.8 SWOT Analysis
• 11.9 Biomet, Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Insights
  • 11.9.3 Product Benchmarking
  • 11.9.4 Key Developments
  • 11.9.5 Winning Imperatives
  • 11.9.6 Current Focus & Strategies
  • 11.9.7 Threat from Competition
  • 11.9.8 SWOT Analysis
• 11.10 Acumed
  • 11.10.1 Company Overview
  • 11.10.2 Company Insights
  • 11.10.3 Product Benchmarking
  • 11.10.4 Key Developments
  • 11.10.5 Winning Imperatives
  • 11.10.6 Current Focus & Strategies
  • 11.10.7 Threat from Competition
  • 11.10.8 SWOT Analysis

12 VERIFIED MARKET INTELLIGENCE

• 12.1 About Verified Market Intelligence
• 12.2 Dynamic Data Visualization